Core Insights - JD Health and Junshi Biosciences have established a strategic partnership to enhance ecological services for oral mucositis care in cancer patients [1][2] - The collaboration aims to integrate JD Health's resources in medical services and instant retail to create a comprehensive ecosystem for oral care [1][3] Group 1: Partnership Details - The partnership focuses on a core model of "professional medical services + compliant supply + instant accessibility" [1] - The newly launched oral mucosal liquid dressing, Su Shu®, is exclusively available on JD Health, providing a full-chain solution for oral health [1][2] Group 2: Clinical Context - Clinical data indicates that 20%-40% of patients undergoing chemotherapy experience oral mucositis, with over 80% of radiotherapy patients suffering from moderate to severe pain [2] - Oral mucositis significantly impacts patients' quality of life and can lead to treatment delays, increased costs, and heightened psychological burdens [2] Group 3: Product and Service Integration - JD Health leverages its online consultation, pharmaceutical retail, and rapid delivery capabilities to create a three-in-one service system for cancer patients [1][3] - The collaboration addresses key pain points in care, such as the difficulty in obtaining compliant devices and the lack of professional guidance [1][3] Group 4: Strategic Implications - Junshi Biosciences aims to focus on comprehensive health management for cancer patients, with Su Shu® representing a strategic shift towards integrated health management [2][3] - The partnership exemplifies the integration of medical and retail resources in specialized healthcare scenarios, setting a benchmark in the medical device sector [3]